(These articles have been accepted for this issue. Change is possible before publication.)

    Volume 14, Number 11

ORIGINAL PAPERS

BREAST CANCER

CANCER DIAGNOSTICS AND MOLECULAR PATHOLOGY

THE COMMUNITY ONCOLOGIST

HEPATOBILIARY CANCER

LUNG CANCER

REGULATORY ISSUES: FDA

SARCOMAS

SYMPTOM MANAGEMENT AND SUPPORTIVE CARE

   ORIGINAL PAPERS

   BREAST CANCER

Long-Term Outcomes in Stage IIIB Breast Cancer Patients Who Achieved Less Than a Pathological Complete Response After Primary Chemotherapy

Maria Teresa Ionta, Francesco Atzori, Maria Cristina Deidda, Valeria Pusceddu, Sergio Palmeri, Barbara Frau, Monica Murgia, Michela Barca, Luigi Minerba, Bruno Massidda

Beyond Trastuzumab: Small Molecule Tyrosine Kinase Inhibitors in HER-2 Positive Breast Cancer

Vivek Roy, Edith A. Perez

Circulating Tumor Cells: Evolving Evidence and Future Challenges

Efrat Dotan, Steven J. Cohen, Katherine R. Alpaugh, Neal J. Meropol

Case Report: A Case of Advanced Medullary Thyroid Carcinoma Successfully Treated with Sunitinib

Maria João Bugalho, Rita Domingues, Alexandra Borges

Case Report: Uncommon Manifestation of Disease: Peliosis Hepatis as Cardinal Symptom of Hodgkin's Lymphoma

Alexander Kleger, Martin Bommer, Markus Kunze, Jochen Klaus, Frank Leithäuser, Martin Wegener, Guido Adler, Nektarios Dikopoulos

Hepatic Toxicities Associated with the Use of Preoperative Systemic Therapy in Patients with Metastatic Colorectal Adenocarcinoma to the Liver

James M. Cleary, Kenneth T. Tanabe, Gregory Y. Lauwers, Andrew X. Zhu

Prognostic Factors for Resected Non-Small Cell Lung Cancer with pN2 Status: Implications for Use of Postoperative Radiotherapy

Luigi Moretti, David S. Yu, Heidi Chen, David P. Carbone, David H. Johnson, Vicki L. Keedy, Joe B. Putnam, Jr., Alan B. Sandler, Yu Shyr, Bo Lu

The Role of EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer

Mandira Ray, Ravi Salgia, Everett E. Vokes

FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme

Martin H. Cohen, Yuan Li Shen, Patricia Keegan, Richard Pazdur

Current Approach to Pediatric Soft Tissue Sarcomas

Melinda S. Merchant, Crystal L. Mackall

Bisphosphonates and Time to Osteonecrosis Development

Athanasios I. Zavras, Vassiliki Cartsos, Pinelopi Kleio Palaska